HRT Financial’s Clarivate CLVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.8M Buy
3,479,417
+2,435,672
+233% +$6.24M 0.02% 672
2025
Q4
$3.49M Buy
1,043,745
+948,891
+1,000% +$3.37M 0.01% 965
2025
Q3
$363K Sell
94,854
-871,969
-90% -$3.66M ﹤0.01% 2065
2025
Q2
$4.16M Buy
966,823
+825,123
+582% +$3.32M 0.02% 611
2025
Q1
$556K Sell
141,700
-29,138
-17% -$138K ﹤0.01% 1412
2024
Q4
$867K Buy
+170,838
New +$984K ﹤0.01% 1139
2024
Q3
Sell
-623,918
Closed -$3.55M 2513
2024
Q2
$3.55M Buy
+623,918
New +$3.98M 0.02% 512
2024
Q1
Sell
-208,019
Closed -$1.93M 2408
2023
Q4
$1.93M Buy
+208,019
New +$1.54M 0.01% 665
2023
Q3
Sell
-209,550
Closed -$2M 2468
2023
Q2
$2M Buy
+209,550
New +$1.78M 0.02% 611
2022
Q4
Sell
-73,052
Closed -$685K 2544
2022
Q3
$685K Buy
+73,052
New +$925K 0.01% 1249

Other funds holding CLVT

HRT Financial's CLVT Position: Q1 2026 in Review

HRT Financial increased its Clarivate (CLVT) stake by 233% in Q1 2026, buying an estimated $6.24M and bringing the position to 3,479,417 shares worth $8.8M. The position accounts for 0.02% of the portfolio, ranked #672.

HRT Financial first reported a position in CLVT in Q3 2022 and has held it in 10 quarters since. 254 funds tracked by Wall St. Rank hold CLVT as of Q1 2026.

  • HRT Financial held 3,479,417 shares of Clarivate worth $8.8M as of Q1 2026.
  • HRT Financial bought 2,435,672 Clarivate shares in Q1 2026, an estimated $6.24M.
  • Clarivate made up 0.02% of HRT Financial's portfolio in Q1 2026, its #672 holding.
  • HRT Financial first reported a position in Clarivate in Q3 2022 and has held it in 10 quarters since.
  • 254 funds tracked by Wall St. Rank held Clarivate as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.